Observed Signal · Aug 28, 2026 · Market Signal · Source: Doximity · Impact: 4/5

Penn Highlands Healthcare Partners with Doximity to Launch System-Wide Clinical AI Suite

Executive Signal Summary

Doximity announces a partnership with Penn Highlands Healthcare to deploy its Clinical AI Suite system-wide.

SIGNAL RADAR

Track Doximity Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.

Start Monitoring
Verified primary sourcesAutomated briefingsInstant watchlist setup
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: Doximity•Published: Aug 28, 2026

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Market IntelligenceSep 3, 2026

Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic

Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.

Read assessment
Health / AIOct 7, 2026

Healthleap Raises $38M for AI-Powered Hospital Patient Screening

Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.

Read assessment
FinancialsAug 7, 2026

Doximity Shares More Than Double After AI Remarks

Shares of Doximity more than doubled in premarket trading after CEO Jeffrey Tangney said the company’s new AI search product generates over ten times the revenue per search versus its cost. Doximity reported fiscal Q1 2027 revenue of $156.6 million and adjusted EBITDA of $74.8 million, both beating estimates, and raised its full-year revenue guidance by $6 million to a range of $671 million–$681 million. Analysts note that the updated guidance likely does not fully incorporate AI search revenue. Elevated short interest (about 17% of float) contributed to a rapid squeeze as positions were unwound. The stock surge followed comments on AI unit economics made on the company’s earnings call.

Read assessment
Executive Briefing & Watchlist

Receive all future signals for Doximity & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Daily primary source scansCurated executive briefingsUnsubscribe anytime